fosinopril &#160; Turanci (Q425293)

https://www.whocc.no/atc_ddd_index/?code=C09AA09

active ingredient in ^Turanci

Monopril ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

225030

retrieved ^Turanci

14 Faburairu 2018

medical condition treated ^Turanci

congestive heart failure ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

Hawan jini

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

Hukumar Abinci da Magunguna

harshen aiki ko suna

Turanci

retrieved ^Turanci

13 Disamba 2016

stated in ^Turanci

Drug Indications Extracted from FAERS ^Turanci

retrieved ^Turanci

2 Oktoba 2018

Hawan jini

lokacin farawa

30 Nuwamba 2003

approved by ^Turanci

1 reference

stated in ^Turanci

Inxight: Drugs Database ^Turanci

retrieved ^Turanci

2 Nuwamba 2018

https://www.drugs.com/pro/fosinopril.html

significant drug interaction ^Turanci

valsartan ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

telmisartan ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

eprosartan ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

irbesartan ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

candesartan ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

losartan ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

olmesartan ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

azilsartan ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

eplerenone ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

bendroflumethiazide ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorthalidone ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(2RS,6RS)-clopamide ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

bromocriptine ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

bumetanide ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

furosemide ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

spironolactone ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

hydrochlorothiazide ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

indapamide ^Turanci

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

valsartan ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

valsartan ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

valsartan ^Turanci

syncope ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

valsartan ^Turanci

kidney failure ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

telmisartan ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

telmisartan ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

telmisartan ^Turanci

syncope ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

telmisartan ^Turanci

kidney failure ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

eprosartan ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

eprosartan ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

eprosartan ^Turanci

syncope ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

eprosartan ^Turanci

kidney failure ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

irbesartan ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

irbesartan ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

irbesartan ^Turanci

syncope ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

irbesartan ^Turanci

kidney failure ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

candesartan ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

candesartan ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

candesartan ^Turanci

syncope ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

candesartan ^Turanci

kidney failure ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

losartan ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

losartan ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

losartan ^Turanci

syncope ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

losartan ^Turanci

kidney failure ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

olmesartan ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

olmesartan ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

olmesartan ^Turanci

syncope ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

olmesartan ^Turanci

kidney failure ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

azilsartan ^Turanci

acute kidney injury ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

azilsartan ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

azilsartan ^Turanci

syncope ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

azilsartan ^Turanci

kidney failure ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

eplerenone ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

spironolactone ^Turanci

hyperkalemia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

bendroflumethiazide ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorthalidone ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(2RS,6RS)-clopamide ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

hydrochlorothiazide ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

indapamide ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

bromocriptine ^Turanci

hyperinsulinism ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

bumetanide ^Turanci

orthostatic hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

furosemide ^Turanci

orthostatic hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

legal status (medicine) ^Turanci

boxed warning ^Turanci

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

laƙabi

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (Turanci)

pregnancy category ^Turanci

Australian pregnancy category D ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

US pregnancy category C ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

subject has role ^Turanci

ACE inhibitor ^Turanci

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

5 Maris 2018

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

antihypertensive drug ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

NCI Thesaurus ID ^Turanci

C65761

1 reference

stated in ^Turanci

UNII ^Turanci

InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30?,39?/m1/s1

retrieved ^Turanci

15 Faburairu 2018

has part(s) ^Turanci

N

0 references

C

0 references

Commons category ^Turanci

Fosinopril

0 references

Identifiers

InChI ^Turanci

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

fosinopril (Turanci)

retrieved ^Turanci

20 Satumba 2016

InChIKey ^Turanci

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

fosinopril (Turanci)

retrieved ^Turanci

20 Satumba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

98048-97-6

2 references

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Fosinopril (Turanci)

17 Nuwamba 2015

stated in ^Turanci

UNII ^Turanci

retrieved ^Turanci

15 Faburairu 2018

ChemSpider ID ^Turanci

50469

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

(4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-proline (Turanci)

retrieved ^Turanci

20 Satumba 2016

PubChem CID ^Turanci

55891

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

fosinopril (Turanci)

retrieved ^Turanci

20 Satumba 2016

InChIKey ^Turanci

Reaxys registry number ^Turanci

8176492

0 references

ChEBI ID ^Turanci

5163

mapping relation type ^Turanci

exact match ^Turanci

2 references

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

CHEMBL3306578 (Turanci)

retrieved ^Turanci

20 Satumba 2016

InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30?,39?/m1/s1

International Chemical Identifier ^Turanci

InChI ^Turanci

ChEMBL ID ^Turanci

CHEMBL3306578

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

CHEMBL3306578 (Turanci)

retrieved ^Turanci

20 Satumba 2016

CHEMBL3039598

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

FOSINOPRIL (Turanci)

retrieved ^Turanci

3 Oktoba 2016

SureChEMBL ID ^Turanci

SCHEMBL15626

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

InChIKey ^Turanci

MSBNK-Athens_Univ-AU224701

UniChem compound ID ^Turanci

1065574

1 reference

stated in ^Turanci

UniChem ^Turanci

MassBank accession ID ^Turanci

0 references

MSBNK-Athens_Univ-AU224702

0 references

MSBNK-Athens_Univ-AU224703

0 references

MSBNK-Athens_Univ-AU224704

0 references

MSBNK-Athens_Univ-AU224705

0 references

MSBNK-Athens_Univ-AU224707

0 references

MSBNK-Athens_Univ-AU224708

0 references

MSBNK-Athens_Univ-AU224709

0 references

MSBNK-Athens_Univ-AU224710

0 references

MSBNK-Athens_Univ-AU224711

0 references

MSBNK-Athens_Univ-AU224734

0 references

MSBNK-Athens_Univ-AU224751

0 references

MSBNK-Athens_Univ-AU224752

0 references

MSBNK-Athens_Univ-AU224753

0 references

MSBNK-Athens_Univ-AU224754

0 references

MSBNK-Athens_Univ-AU224755

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

SPLASH ^Turanci

splash10-000i-0000900000-0eee13fe1a605e98c985

0 references

splash10-00ku-0105900000-1253dd1cea86dcfde7f6

0 references

splash10-0udl-0908200000-59ff4955c6e6b2d36435

0 references

splash10-0udi-0901000000-e2b0d1bb8bfd4d6f7595

0 references

splash10-014i-0000900000-f61a6a8a62cc0c92102b

0 references

splash10-014i-0000900000-ed280398ec57e4a02dce

0 references

splash10-00di-0090300000-4e1c300644a39a64aefe

0 references

splash10-00di-0090000000-85f8c80f83290feea35c

0 references

splash10-00di-0090000000-e28a43e299ff58e3a6bc

0 references

splash10-000i-0000900000-f625a00c8eb75cbf317d

0 references

splash10-0f6x-0409200000-5a18b8096c457898aa5f

0 references

splash10-0udi-0900000000-28e69824d7a0442561b6

0 references

splash10-0udi-0900000000-aa95f5f65aec2f92a48a

0 references

splash10-0udi-2900000000-48b3327e8691a43ae029

0 references

splash10-0udi-6900000000-de8ad752f1c8f05aded2

0 references

splash10-014i-0010900000-a142ed389f6652d197f1

0 references

splash10-00di-1090000000-833fa43a37b31e08737c

0 references

splash10-00di-1090000000-cda46913f10b57e39204

0 references

splash10-00di-2290000000-8627963d14d5d091e338

0 references

splash10-0229-7890000000-a5186e8ef5fa038d0a91

0 references

splash10-03k9-9720000000-ff0242177e3d4ef6c38a

0 references

DSSTox substance ID ^Turanci

DTXSID1023079

2 references

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

InChIKey ^Turanci

DSSTOX compound identifier ^Turanci

DTXCID003079

0 references

Lambar ATC

C09AA09

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Fosinopril (Turanci)

17 Nuwamba 2015

Guide to Pharmacology Ligand ID ^Turanci

6456

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

retrieved ^Turanci

8 Faburairu 2021

MeSH descriptor ID ^Turanci

subject named as ^Turanci

Fosinopril

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

14 Maris 2018

Lambar itace MeSH

D02.705.629.500

0 references

D12.125.072.401.623.374

0 references

RxNorm ID ^Turanci

50166

1 reference

stated in ^Turanci

UNII ^Turanci

retrieved ^Turanci

15 Faburairu 2018

Human Metabolome Database ID ^Turanci

HMDB0014635

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

InChIKey ^Turanci

UNII ^Turanci

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

FOSINOPRIL (Turanci)

retrieved ^Turanci

19 Janairu 2016

stated in ^Turanci

UNII ^Turanci

retrieved ^Turanci

15 Faburairu 2018

8B3FLG23GN

1 reference

InChIKey ^Turanci

MedlinePlus drug identifier ^Turanci

a692020

0 references

PatientsLikeMe treatment ID ^Turanci

fosinopril

0 references

NDF-RT ID ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

FOSINOPRIL (Turanci)

retrieved ^Turanci

19 Janairu 2016

Probes And Drugs ID ^Turanci

PD009996

0 references

KEGG ID ^Turanci

D00622

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

Fosinopril (Turanci)

retrieved ^Turanci

19 Janairu 2016

DeCS ID ^Turanci

30725

0 references

Freebase ID ^Turanci

/m/038t1_

1 reference

stated in ^Turanci

Freebase Data Dumps ^Turanci

ranar wallafa

28 Oktoba 2013

KBpedia ID ^Turanci

Fosinopril

1 reference

stated in ^Turanci

KBpedia ^Turanci

retrieved ^Turanci

9 Yuli 2020

Microsoft Academic ID ^Turanci

2780436477

0 references

OpenAlex ID ^Turanci

C2780436477

1 reference

stated in ^Turanci

OpenAlex ^Turanci

retrieved ^Turanci

26 Janairu 2022